UBS O'Connor’s Connect Biopharma Holdings Limited Ordinary Shares CNTB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-268,946
| Closed | -$148K | – | 314 |
|
2025
Q1 | $148K | Sell |
268,946
-241,755
| -47% | -$133K | ﹤0.01% | 224 |
|
2024
Q4 | $705K | Hold |
510,701
| – | – | 0.02% | 251 |
|
2024
Q3 | $725K | Hold |
510,701
| – | – | 0.02% | 305 |
|
2024
Q2 | $776K | Hold |
510,701
| – | – | 0.02% | 323 |
|
2024
Q1 | $889K | Sell |
510,701
-50,490
| -9% | -$87.9K | 0.03% | 283 |
|
2023
Q4 | $662K | Sell |
561,191
-42,709
| -7% | -$50.4K | 0.02% | 312 |
|
2023
Q3 | $469K | Hold |
603,900
| – | – | 0.01% | 389 |
|
2023
Q2 | $670K | Buy |
603,900
+29,752
| +5% | +$33K | 0.01% | 414 |
|
2023
Q1 | $574K | Buy |
+574,148
| New | +$574K | 0.01% | 444 |
|
2022
Q4 | – | Sell |
-613,931
| Closed | -$792K | – | 69 |
|
2022
Q3 | $792K | Sell |
613,931
-37,575
| -6% | -$48.5K | 0.01% | 752 |
|
2022
Q2 | $567K | Buy |
+651,506
| New | +$567K | 0.01% | 791 |
|